| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Crutchfield Bradford is a Chief Commercial Officer at 10x Genomics, Inc.. Recent SEC Form 4 filings include 0 buys and 54 sells.
Estimated insider holdings value: $2.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2020 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sale+OE | 17,000 | $151.29 | $2,571,982.33 | -37.0% | |
| Nov 3, 2020 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sale+OE | 17,000 | $136.68 | $2,323,514.98 | -34.5% | |
| Oct 1, 2020 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sale+OE | 17,000 | $125.43 | $2,132,260.03 | -43.1% | |
| Sep 2, 2020 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sale+OE | 17,000 | $113.67 | $1,932,383.63 | -37.1% | |
| Aug 3, 2020 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sale+OE | 17,000 | $99.33 | $1,688,606.48 | -55.5% | |
| Jul 1, 2020 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sale+OE | 17,000 | $87.60 | $1,489,135.67 | -63.2% | |
| Jun 1, 2020 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sale+OE | 17,000 | $79.84 | $1,357,223.87 | -27.2% | |
| May 1, 2020 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sale+OE | 17,000 | $77.38 | $1,315,469.37 | -56.7% | |
| Apr 1, 2020 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sale+OE | 17,000 | $58.06 | $987,006.13 | -66.4% | |
| Mar 6, 2020 | TXG 10x Genomics, Inc. | Chief Commercial Officer | Sale+OE | 17,000 | $65.91 | $1,120,476.63 | -24.7% |